Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium
- PMID: 23300321
- PMCID: PMC4089029
- DOI: 10.3382/ps.2012-02708
Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium
Abstract
There has been a resurgent interest in the use of bacteriophages or their gene products to control bacterial pathogens as alternatives to currently used antibiotics. Clostridium perfringens is a gram-positive, spore-forming anaerobic bacterium that plays a significant role in human foodborne disease as well as non-foodborne human, animal, and avian diseases. Countries that have complied with the ban on antimicrobial growth promoters in feeds have reported increased incidences of C. perfringens-associated diseases in poultry. To address these issues, new antimicrobial agents, putative lysins encoded by the genomes of bacteriophages, are being identified in our laboratory. Poultry intestinal material, soil, sewage, and poultry processing drainage water were screened for virulent bacteriophages that could lyse C. perfringens and produce clear plaques in spot assays. Bacteriophages were isolated that had long noncontractile tails, members of the family Siphoviridae, and with short noncontractile tails, members of the family Podoviridae. Several bacteriophage genes were identified that encoded N-acetylmuramoyl-l-alanine amidases, lysozyme-endopeptidases, and a zinc carboxypeptidase domain that has not been previously reported in viral genomes. Putative phage lysin genes (ply) were cloned and expressed in Escherichia coli. The recombinant lysins were amidases capable of lysing both parental phage host strains of C. perfringens as well as other strains of the bacterium in spot and turbidity reduction assays, but did not lyse any clostridia beyond the species. Consequently, bacteriophage gene products could eventually be used to target bacterial pathogens, such as C. perfringens via a species-specific strategy, to control animal and human diseases without having deleterious effects on beneficial probiotic bacteria.
Figures
Similar articles
-
Recombinant expression of two bacteriophage proteins that lyse clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-terminal active domains.J Agric Food Chem. 2010 Oct 13;58(19):10330-7. doi: 10.1021/jf101387v. J Agric Food Chem. 2010. PMID: 20825156 Free PMC article.
-
Molecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the Picovirinae.PLoS One. 2012;7(5):e38283. doi: 10.1371/journal.pone.0038283. Epub 2012 May 29. PLoS One. 2012. PMID: 22666499 Free PMC article.
-
Expression of a Clostridium perfringens genome-encoded putative N-acetylmuramoyl-L-alanine amidase as a potential antimicrobial to control the bacterium.Arch Microbiol. 2013 Nov;195(10-11):675-81. doi: 10.1007/s00203-013-0916-4. Epub 2013 Aug 11. Arch Microbiol. 2013. PMID: 23934074 Free PMC article.
-
Necrotic enteritis in broilers: an updated review on the pathogenesis.Avian Pathol. 2011 Aug;40(4):341-7. doi: 10.1080/03079457.2011.590967. Avian Pathol. 2011. PMID: 21812711 Review.
-
Clostridium perfringens in poultry: an emerging threat for animal and public health.Avian Pathol. 2004 Dec;33(6):537-49. doi: 10.1080/03079450400013162. Avian Pathol. 2004. PMID: 15763720 Review.
Cited by
-
AmiP from hyperthermophilic Thermus parvatiensis prophage is a thermoactive and ultrathermostable peptidoglycan lytic amidase.Protein Sci. 2023 Mar;32(3):e4585. doi: 10.1002/pro.4585. Protein Sci. 2023. PMID: 36721347 Free PMC article.
-
A Broad-Spectrum Phage Endolysin (LysCP28) Able to Remove Biofilms and Inactivate Clostridium perfringens Strains.Foods. 2023 Jan 15;12(2):411. doi: 10.3390/foods12020411. Foods. 2023. PMID: 36673503 Free PMC article.
-
Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii-An in silico approach.Front Med (Lausanne). 2022 Nov 4;9:1047752. doi: 10.3389/fmed.2022.1047752. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36405598 Free PMC article.
-
The Broad Host Range Phage vB_CpeS_BG3P Is Able to Inhibit Clostridium perfringens Growth.Viruses. 2022 Mar 25;14(4):676. doi: 10.3390/v14040676. Viruses. 2022. PMID: 35458406 Free PMC article.
-
Phage therapy as a revolutionary medicine against Gram-positive bacterial infections.Beni Suef Univ J Basic Appl Sci. 2021;10(1):49. doi: 10.1186/s43088-021-00141-8. Epub 2021 Aug 28. Beni Suef Univ J Basic Appl Sci. 2021. PMID: 34485539 Free PMC article. Review.
References
-
- Ackermann H-W. Classification of Bacillus and Clostridium bacteriophages. Pathol. Biol. (Paris) 1974;22:909–917. - PubMed
-
- Ackermann H-W. Bacteriophage observations and evolution. Res. Microbiol. 2003;154:245–251. - PubMed
-
- Ackermann H-W. Classification of Bacteriophages. In: Calendar R, Abedon ST, editors. The Bacteriophages. Oxford University Press; Oxford, UK: 2006. pp. 8–16.
-
- Ackermann H-W. 5500 Phages examined in the electron microscope. Arch. Virol. 2007;152:227–243. - PubMed
-
- Bedford M. Removal of antibiotic growth promoters from poultry diets: Implications and strategies to minimize subsequent problems. World’s Poult. Sci. J. 2000;56:347–365.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources